Mechanisms such as the acceleration of subclinical atherosclerosis and reduction of arterial compliance [78], exacerbation of chronic inflammation, and oxidative stress and abnormal activation of the renin–angiotensin–aldosterone system have been proposed to contribute to the development of HTN in patients with DPN [79]. Here, REN is linked to hypertensive disorder.